Shawn Cross insider trades: Pacira BioSciences (PCRX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Shawn reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | PCRX | ↓ Sell10b5-1 | 12,059 | $25.09 | $303K | Direct | Apr 22, 2026 (0d) |
| Dec 10, 2025 | PCRX | ↓ Sell10b5-1 | 25,000 | $25.07 | $627K | Direct | Dec 11, 2025 (1d) |
| Nov 10, 2025 | PCRX | ↓ Sell10b5-1 | 12,060 | $22.09 | $266K | Direct | Nov 13, 2025 (3d) |
| Nov 22, 2023 | AMTI | ↓ Sell | 110,802 | $0.16 | $18K | Direct | Nov 24, 2023 (2d) |
| Nov 15, 2023 | AMTI | ↓ Sell | 90,447 | $0.16 | $15K | Direct | Nov 16, 2023 (1d) |
| Sep 29, 2023 | AMTI | ↓ Sell | 193,960 | $0.16 | $31K | Direct | Oct 2, 2023 (3d) |
| Sep 5, 2023 | AMTI | ↓ Sell | 5,559 | $0.23 | $1K | Direct | Oct 4, 2023 (29d) |
| Mar 1, 2023 | AMTI | ↓ Sell | 934 | $0.50 | $467 | Direct | Mar 3, 2023 (2d) |
| Dec 2, 2022 | AMTI | ↓ Sell | 3,893 | $1.05 | $4K | Direct | Dec 6, 2022 (4d) |
| Sep 1, 2022 | AMTI | ↓ Sell | 884 | $1.42 | $1K | Direct | Sep 6, 2022 (5d) |
| Jun 2, 2022 | AMTI | ↓ Sell | 3,933 | $3.01 | $12K | Direct | Jun 3, 2022 (1d) |
| Aug 23, 2021 | AMTI | ↓ Sell | 10,000 | $30.12 | $301K | Direct | Aug 23, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PCRX insiders
Open-market trades in the last 12 months
About Shawn Cross's insider trades
Shawn Cross is Chief Financial Officer at Pacira BioSciences (PCRX). Since Aug 23, 2021, Shawn has reported no open-market purchases and 12 sales worth $1.6M on SEC Form 4. In the last 12 months: 3 sales ($1.2M).
3 sales (76% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (12 filings), option exercises (3 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.